{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T13:06:53Z","timestamp":1759496813907},"reference-count":30,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.3892\/ol.2016.4299","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T07:41:56Z","timestamp":1456904516000},"page":"2747-2750","source":"Crossref","is-referenced-by-count":3,"title":["Pathological complete response following neoadjuvant radiotherapy and intraperitoneal perfusion chemotherapy for recurrent colon carcinoma: A case report and literature review"],"prefix":"10.3892","volume":"11","author":[{"given":"XINYU","family":"BIAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BAORUI","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YANG","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"key":"key20180108094435_b1-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key20180108094435_b2-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ctrv.2015.06.007","article-title":"Rectal and colon cancer: Not just a different anatomic site","volume":"41","author":"Tamas","year":"2015","journal-title":"Cancer treatment reviews"},{"key":"key20180108094435_b3-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-129-1-199807010-00007","article-title":"Surgery for recurrent colon cancer: Strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group","volume":"129","author":"Goldberg","year":"1998","journal-title":"Ann Intern Med"},{"key":"key20180108094435_b4-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/1097-0142(19880501)61:9<1913::AID-CNCR2820610932>3.0.CO;2-Y","article-title":"Multiple reoperations in recurrent colorectal carcinoma. An analysis of morbidity, mortality and survival","volume":"61","author":"Sardi","year":"1988","journal-title":"Cancer"},{"key":"key20180108094435_b5-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF01789203","article-title":"Prevention and management of recurrent rectal cancer","volume":"15","author":"Beart","year":"1991","journal-title":"World J Surg"},{"key":"key20180108094435_b6-ol-0-0-4299","first-page":"9286","article-title":"Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer","volume":"20","author":"Sugarbaker","year":"2014","journal-title":"World J Gastroenterol"},{"key":"key20180108094435_b7-ol-0-0-4299","first-page":"915078","article-title":"Second-look surgery for colorectal cancer: Revised selection factors and new treatment options for greater success","volume":"2011","author":"Sugarbaker","year":"2011","journal-title":"Int J Surg Oncol"},{"key":"key20180108094435_b8-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0959-8049(99)00150-1","article-title":"CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR","volume":"35","author":"Andr\u00e9","year":"1999","journal-title":"Eur J Cancer"},{"key":"key20180108094435_b9-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1245\/s10434-007-9348-1","article-title":"Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43\u00b0C after compete cytoreductive surgery: Mortality and morbidity in 106 consecutive patients","volume":"14","author":"Elias","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"key20180108094435_b10-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/annonc\/mdh398","article-title":"Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: Pharmacokinetics, tissue distribution and tolerance","volume":"15","author":"Elias","year":"2004","journal-title":"Ann Oncol"},{"key":"key20180108094435_b11-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-1-31","article-title":"Dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies","volume":"1","author":"Kataria","year":"2006","journal-title":"Radiat Oncol"},{"key":"key20180108094435_b12-ol-0-0-4299","first-page":"726","article-title":"The grading of carcinoma","volume":"8","author":"Broders","year":"1925","journal-title":"Minn Med"},{"key":"key20180108094435_b13-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02557371","article-title":"The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancer","volume":"9","author":"Taylor","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"key20180108094435_b14-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/1097-0142(19800615)45:12<2969::AID-CNCR2820451214>3.0.CO;2-7","article-title":"Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum","volume":"45","author":"Olson","year":"1980","journal-title":"Cancer"},{"key":"key20180108094435_b15-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00000658-198412000-00001","article-title":"Failure patterns following curative resection of colonic carcinoma","volume":"200","author":"Willett","year":"1984","journal-title":"Ann Surg"},{"key":"key20180108094435_b16-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0002-9610(92)90554-5","article-title":"Extended resection for locally advanced colorectal carcinoma","volume":"163","author":"Curley","year":"1992","journal-title":"Am J Surg"},{"key":"key20180108094435_b17-ol-0-0-4299","first-page":"787","article-title":"Local recurrence after curative resection of colorectal adenocarcinoma","volume":"108","author":"Michelassi","year":"1990","journal-title":"Surgery"},{"key":"key20180108094435_b18-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00003088-199733040-00001","article-title":"Clinical pharmacokinetics of irinotecan","volume":"33","author":"Chabot","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"key20180108094435_b19-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group","volume":"343","author":"Saltz","year":"2000","journal-title":"N Engl J Med"},{"key":"key20180108094435_b20-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1245\/s10434-009-0669-0","article-title":"Combination intraperitoneal chemotherapy is superior to mitomycin C or oxaliplatin for colorectal carcinomatosis in vivo","volume":"17","author":"Cohen","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"key20180108094435_b21-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Gynecologic Oncology Group: Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180108094435_b22-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N Engl J Med"},{"key":"key20180108094435_b23-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00280-010-1272-6","article-title":"Phase I study of intraperitoneal irinotecan in patients with gastric adenocarcinoma with peritoneal seeding","volume":"67","author":"Choi","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180108094435_b24-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/jso.21569","article-title":"Pharmacokinetics of intraperitoneal irinotecan in a pig model","volume":"101","author":"Turcotte","year":"2010","journal-title":"J Surg Oncol"},{"key":"key20180108094435_b25-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0360-3016(03)00325-0","article-title":"Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy","volume":"56","author":"Mundt","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180108094435_b26-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0360-3016(02)02823-7","article-title":"Intensity-modulated radiation therapy (IMRT) for meningioma","volume":"53","author":"Uy","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180108094435_b27-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0360-3016(02)03746-X","article-title":"Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy","volume":"54","author":"Vicini","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180108094435_b28-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"778","DOI":"10.6004\/jnccn.2009.0056","article-title":"NCCN Clinical Practice Guidelines in Oncology: Colon cancer","volume":"7","author":"Engstrom","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"key20180108094435_b29-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1245\/s10434-014-3647-0","article-title":"Pathological response to neoadjuvant chemotherapy: A new prognosis tool for the curative management of peritoneal colorectal carcinomatosis","volume":"21","author":"Passot","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"key20180108094435_b30-ol-0-0-4299","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2006.05.8727","article-title":"Complete response of colorectal liver metastases after chemotherapy: Does it mean cure?","volume":"24","author":"Benoist","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.4299\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T11:19:44Z","timestamp":1515410384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.4299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,3,2]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.3892\/ol.2016.4299"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.4299","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,2]]}}}